Clinical Trials Logo

Clinical Trial Summary

Respiratory distress is one of the first hospital grounds during the neonatal period. The clinical presentation and severity vary by gestational age and cause. She reports to various etiological factors as maternal, neonatal or sometimes entangled. The symptomatic management has benefited from organizational progress (perinatal care) and techniques, including antenatal steroids, the use of exogenous surfactant and non-invasive ventilation early, so that the use of intubation is less frequent. The short-term evolution of patients with early respiratory distress is based on gestational age, cause and initial management.


Clinical Trial Description

Main objective: To describe the care and short-term respiratory become newborns 32 weeks gestation or older with early and persistent respiratory distress to 2 hours of life (H2) over a period of one year in a type IIb motherhood. Methodology : Design: retrospective, descriptive, single-center, non-interventional Performed in the Saint Joseph neonatal unit. Study duration: 1 year (01/05/2013-04/30/2014). Acquisition of data: The patients were selected from the hospitalization reports of infants by taking the following key words: respiratory distress, invasive and noninvasive ventilation, intubation, exogenous surfactant, pneumothorax. Data collected: - Obstetric data: - Mode of delivery: route of delivery, presentation at birth. - Maternal morbidity. - antenatal corticosteroids in infants less than 34 weeks. - Neonatal data: - Gestational Age - Birth Weight - cord pH - Apgar M5 - The terms of the allocation: - Tracheal Intubation - ventilation modes (controlled mechanical ventilation (VMC), non-invasive ventilation (NIV), nasal cannula), the maximum reached FiO2 (fraction of inspired oxygen), ventilation time for each ventilation mode. These different methods were studied in the delivery room during hospitalization (in intensive care and neonatal intensive care "NICU"). - The place of hospitalization: resuscitation and / or NICU. - The transfer to the NICU resuscitation if necessary. - Received drugs (exogenous surfactant, antibiotics, caffeine) - The successful primary diagnosis. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02824497
Study type Observational
Source Groupe Hospitalier Paris Saint Joseph
Contact
Status Completed
Phase
Start date May 2015
Completion date May 2015

See also
  Status Clinical Trial Phase
Completed NCT02522455 - Flow-cycled Ventilation in Preterm Infants N/A
Not yet recruiting NCT04019886 - Impact of Neurophysiological Facilitation of Respiration in Preterm Neonates N/A
Terminated NCT02999165 - Breastfeeding Infants Receiving Respiratory Support Trial
Completed NCT02112513 - The Use of Maternal Serum Unconjugated Estriol for Monitoring the Prevention of Neonatal Respiratory Distress Syndrome
Completed NCT04000568 - Breathing Variability and NAVA in Neonates
Completed NCT01926106 - Nasal Intermittent Positive-Pressure Ventilation for Twin Infants With Respiratory Distress Syndrome N/A
Completed NCT02819050 - Effective Approaches & Strategies to Ease Off Nasal CPAP In Preterm Infants N/A
Completed NCT02041676 - Chest Physiotherapy Technique Increasing Inspiratory Flow on Weaning From Non Invasive Ventilation N/A
Completed NCT02333669 - Association of SCNN1A Single Nucleotide Polymorphisms With Neonatal Respiratory Distress Syndrome N/A
Recruiting NCT04409665 - The Use of Sedation Drugs in the Procedure of Administering Surfactant Without Intubation (LISA/MIST) Phase 1
Completed NCT03446937 - Effect of Antenatal Corticosteroids on Neonatal Morbidity. N/A
Terminated NCT03235986 - A Study To InvestigateThe Safety, Tolerability And Efficacy Of Nebulised Curosurf® In Preterm Neonates With Respiratory Distress Syndrome (RDS) Phase 2
Recruiting NCT06367881 - Assessment Of Dose-Dependent Immunomodulatory Effect Of Alveofact With or Without Steroisd In Neonatal RDS Phase 1